EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements
- The Company's common stock maintained a closing bid price of $1.00 per share or greater for 10 consecutive business days, meeting the Minimum Bid Price Requirement
- The Company's market value of listed securities was $35 million or greater for 10 consecutive business days, meeting the MVLS Requirement
- None.
Singapore, Sept. 22, 2023 (GLOBE NEWSWIRE) -- As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on August 10, 2023 indicating that the Company was not in compliance with the
As previously disclosed, the Company received a written notice from Nasdaq on July 31, 2023 indicating that the Company had failed to maintain a minimum market value of listed securities of
All matters relating to the Company’s previous non-compliance with the Nasdaq Capital Market’s continued listing rules are now closed.
For investor and media inquiries, please contact:
Dr. Kelvin Chen
Chief Executive Officer
EUDA Health Holdings Limited
+65 6268 6821
kelvin@euda.com